---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-042670"
form_type: "8-K"
ticker: "LTRN"
cik: "0001763950"
company_name: "Lantern Pharma Inc."
filed_at: "2023-11-24T23:59:59+00:00"
generated_at: "2026-06-07T21:54:40.777827+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Lantern Pharma to repurchase 145K shares from Bios Entities at $3.44/share

## Summary
- Company agreed to buy 145,348 common shares from Bios Fund I entities at $3.44/share, total ~$500K.
- Bios Entities own ~14.7% of outstanding shares; sale for their own working capital and liquidity.
- Transaction expected to close by November 30, 2023; customary reps, warranties, and covenants.
- Buyback represents about 0.5% of shares outstanding (based on recent filings).

## SEC filing metadata
- accession: 0001493152-23-042670
- form_type: 8-K
- ticker: LTRN
- cik: 0001763950
- company_name: Lantern Pharma Inc.
- filed_at: 2023-11-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1763950/000149315223042670/0001493152-23-042670-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1763950/000149315223042670/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-042670
- JSON: https://secwatch.observer/filing/0001493152-23-042670.json
- Plain text: https://secwatch.observer/filing/0001493152-23-042670.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.